Literature DB >> 7533858

Identification of a membrane fusion domain and an oligomerization domain in the baculovirus GP64 envelope fusion protein.

S A Monsma1, G W Blissard.   

Abstract

The baculovirus GP64 envelope fusion protein (GP64 EFP) is the major envelope glycoprotein of the budded virion and has been shown to mediate acid-triggered membrane fusion both in virions and when expressed alone in transfected cells. Using site-directed mutagenesis and functional assays for oligomerization, transport, and membrane fusion, we localized two functional domains of GP64 EFP. To identify a fusion domain in the GP64 EFP of the Orgyia pseudotsugata multiple nuclear polyhedrosis virus (OpMNPV), we examined two hydrophobic regions in the GP64 EFP ectodomain. Hydrophobic region I (amino acids 223 to 228) is a cluster of 6 hydrophobic amino acids exhibiting the highest local hydrophobicity in the ectodomain. Hydrophobic region II (amino acids 330 to 338) lies within a conserved region of GP64 EFP that contains a heptad repeat of leucine residues and is predicted to form an amphipathic alpha-helix. In region I, nonconservative amino acid substitutions at Leu-226 and Leu-227 (at the center of the hydrophobic cluster) completely abolished fusion activity but did not prevent GP64 EFP oligomerization or surface localization. To confirm the role of region I in membrane fusion activity, we used a synthetic 21-amino-acid peptide to generate polyclonal antibodies against region I and demonstrated that antipeptide antibodies were capable of both neutralizing membrane fusion activity and reducing infectivity of the virus. In hydrophobic region II, mutations were designed to disrupt several structural characteristics: a heptad repeat of leucine, a predicted alpha-helix, or the local hydrophobicity along one face of the helix. Single alanine substitutions for heptad leucines did not prevent oligomerization, transport, or fusion activity. However, multiple alanine substitutions or proline (helix-destabilizing) substitutions disrupted both oligomerization and transport of GP64 EFP. In addition, a deletion that removed region II and the predicted alpha-helix was defective for oligomerization, whereas a larger deletion that retained region II and the predicted helix was oligomerized. These results indicate that region II is required for oligomerization and transport and suggest that the predicted helical structure of this region may be important for this function. Thus, by using mutagenesis, functional assays, and antibody inhibition, two functional domains were localized within the baculovirus GP64 EFP: a fusion domain located at amino acids 223 to 228 and an oligomerization domain located at amino acids 327 to 335 within a predicted amphipathic alpha-helix.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7533858      PMCID: PMC188936     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  The pathway of infection of Autographa californica nuclear polyhedrosis virus in an insect host.

Authors:  B A Keddie; G W Aponte; L E Volkman
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  The 64K envelope protein of budded Autographa californica nuclear polyhedrosis virus.

Authors:  L E Volkman
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

4.  'DNA Strider': a 'C' program for the fast analysis of DNA and protein sequences on the Apple Macintosh family of computers.

Authors:  C Marck
Journal:  Nucleic Acids Res       Date:  1988-03-11       Impact factor: 16.971

5.  Shotgun DNA sequencing using cloned DNase I-generated fragments.

Authors:  S Anderson
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

6.  Immunoglobulin G disassembly during thermal denaturation in sodium dodecyl sulfate solutions.

Authors:  E J Victoria; L C Mahan; S P Masouredis
Journal:  Biochemistry       Date:  1977-05-31       Impact factor: 3.162

7.  Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes.

Authors:  Y G Yu; D S King; Y K Shin
Journal:  Science       Date:  1994-10-14       Impact factor: 47.728

8.  Monoclonal antibodies to baculovirus structural proteins: determination of specificities by Western blot analysis.

Authors:  A W Hohmann; P Faulkner
Journal:  Virology       Date:  1983-03       Impact factor: 3.616

9.  Identification and sequence analysis of a gene encoding gp67, an abundant envelope glycoprotein of the baculovirus Autographa californica nuclear polyhedrosis virus.

Authors:  M Whitford; S Stewart; J Kuzio; P Faulkner
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

10.  Location, sequence, transcriptional mapping, and temporal expression of the gp64 envelope glycoprotein gene of the Orgyia pseudotsugata multicapsid nuclear polyhedrosis virus.

Authors:  G W Blissard; G F Rohrmann
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

View more
  47 in total

1.  Stable cell lines expressing baculovirus P35: resistance to apoptosis and nutrient stress, and increased glycoprotein secretion.

Authors:  G Lin; G Li; R R Granados; G W Blissard
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-05       Impact factor: 2.416

2.  Ac23, an envelope fusion protein homolog in the baculovirus Autographa californica multicapsid nucleopolyhedrovirus, is a viral pathogenicity factor.

Authors:  Oliver Y Lung; Marilyn Cruz-Alvarez; Gary W Blissard
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Cyclic avian mass mortality in the northeastern United States is associated with a novel orthomyxovirus.

Authors:  Andrew B Allison; Jennifer R Ballard; Robert B Tesh; Justin D Brown; Mark G Ruder; M Kevin Keel; Brandon A Munk; Randall M Mickley; Samantha E J Gibbs; Amelia P A Travassos da Rosa; Julie C Ellis; Hon S Ip; Valerie I Shearn-Bochsler; Matthew B Rogers; Elodie Ghedin; Edward C Holmes; Colin R Parrish; Chris Dwyer
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

4.  Palmitoylation of the Autographa californica multicapsid nucleopolyhedrovirus envelope glycoprotein GP64: mapping, functional studies, and lipid rafts.

Authors:  Sandy Xiaoxin Zhang; Yu Han; Gary W Blissard
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

5.  A pH-sensitive heparin-binding sequence from Baculovirus gp64 protein is important for binding to mammalian cells but not to Sf9 insect cells.

Authors:  Chunxiao Wu; Shu Wang
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

6.  Initial size and dynamics of viral fusion pores are a function of the fusion protein mediating membrane fusion.

Authors:  Ilya Plonsky; David H Kingsley; Afshin Rashtian; Paul S Blank; Joshua Zimmerberg
Journal:  Biol Cell       Date:  2008-06       Impact factor: 4.458

7.  Mutagenesis and nuclear magnetic resonance analyses of the fusion peptide of Helicoverpa armigera single nucleocapsid nucleopolyhedrovirus F protein.

Authors:  Ying Tan; Ling Jiang; Manli Wang; Feifei Yin; Fei Deng; Maili Liu; Zhihong Hu; Hualin Wang
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

8.  The function of envelope protein P74 from Autographa californica multiple nucleopolyhedrovirus in primary infection to host.

Authors:  Wenke Zhou; Lunguang Yao; Hua Xu; Feng Yan; Yipeng Qi
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

9.  Functional role of the cytoplasmic tail domain of the major envelope fusion protein of group II baculoviruses.

Authors:  Gang Long; Xiaoyu Pan; Marcel Westenberg; Just M Vlak
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

10.  Autographa californica multiple nucleopolyhedrovirus exon0 (orf141), which encodes a RING finger protein, is required for efficient production of budded virus.

Authors:  Xiaojiang Dai; Taryn M Stewart; Joseph A Pathakamuri; Qianjun Li; David A Theilmann
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.